Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
Johnson
R P
RP
Infectious Disease Unit, Massachusetts General Hospital, Charlestown 02129.
Hammond
S A
SA
Trocha
A
A
Siliciano
R F
RF
Walker
B D
BD
D016915:AIDS Vaccines / Q000494:pharmacology*; D000595:Amino Acid Sequence; D000939:Epitopes / Q000235:genetics; D015686:Gene Products, env / Q000235:genetics / Q000276:immunology; D015488:HIV Antigens / Q000235:genetics; D015699:HIV Envelope Protein gp120 / Q000235:genetics / Q000276:immunology; D019302:HIV Envelope Protein gp160; D018023:HIV Seronegativity / Q000276:immunology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D015498:HIV-2 / Q000235:genetics / Q000276:immunology; D015791:HLA-A3 Antigen; D006801:Humans; D007114:Immunization; D066298:In Vitro Techniques; D008969:Molecular Sequence Data; D011498:Protein Precursors / Q000235:genetics / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000494:pharmacology; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology
D016915:AIDS Vaccines; D000939:Epitopes; D015686:Gene Products, env; D015488:HIV Antigens; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D015791:HLA-A3 Antigen; D011498:Protein Precursors; D014614:Vaccines, Synthetic